Recommendations for the Primary Analysis of Continuous Endpoints in Longitudinal Clinical Trials
Drug Information Journal · 2008-07 · 42 (4) · 303-319
DOI: 10.1177/009286150804200402 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Information Journal, online erschienen am 30.12.2008. Verfasst von Craig H. Mallinckrodt und 4 weiteren Autor:innen. Die Arbeit wurde bisher 303-mal zitiert (Crossref) und nennt 58 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Mallinckrodt, C. H., Lane, P. W., Schnell, D., Peng, Y., & Mancuso, J. P. (2008). Recommendations for the Primary Analysis of Continuous Endpoints in Longitudinal Clinical Trials. Drug Information Journal, 42(4), 303-319. https://doi.org/10.1177/009286150804200402
Vancouver
Mallinckrodt CH, Lane PW, Schnell D, Peng Y, Mancuso JP. Recommendations for the Primary Analysis of Continuous Endpoints in Longitudinal Clinical Trials. Drug Information Journal. 2008;42(4):303-319. doi:10.1177/009286150804200402
BibTeX
@article{Mallinckrodt2008,
author = {Mallinckrodt, Craig H. and Lane, Peter W. and Schnell, Dan and Peng, Yahong and Mancuso, James P.},
title = {Recommendations for the Primary Analysis of Continuous Endpoints in Longitudinal Clinical Trials},
journal = {Drug Information Journal},
year = {2008},
volume = {42},
number = {4},
pages = {303--319},
doi = {10.1177/009286150804200402}
}
EUVIMED